# Cognitive Effects of Oral Oxybutynin and Oxybutynin Chloride Topical Gel in Older Volunteers

> **NCT00752141** · PHASE1 · COMPLETED · sponsor: **Watson Pharmaceuticals** · enrollment: 153 (actual)

## Conditions studied

- Healthy Volunteers

## Interventions

- **DRUG:** oxybutynin chloride immediate-release
- **DRUG:** oxybutynin chloride topical gel
- **OTHER:** placebo

## Key facts

- **NCT ID:** NCT00752141
- **Lead sponsor:** Watson Pharmaceuticals
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-09
- **Primary completion:** 2008-10
- **Final completion:** —
- **Target enrollment:** 153 (ACTUAL)
- **Last updated:** 2011-09-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00752141

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00752141, "Cognitive Effects of Oral Oxybutynin and Oxybutynin Chloride Topical Gel in Older Volunteers". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT00752141. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*